American medical technology giant Medtronic CryoCath will invest
$10.7 million to consolidate production operations at its Pointe-Claire plant in Greater Montréal and make it a global centre of excellence. Investissement Québec is providing a non-refundable contribution of
$1.25 million for the expansion.
“The innovative work that led to the creation of the cutting-edge Arctic Front cryoablation system was done in Montréal,” said Mike Coyle, Medtronic’s Executive Vice President and Group President, Cardiac and Vascular Group. “By bringing all our operations together here, we will be able to take advantage of Québec’s expanding life-sciences sector, qualified workforce and world-class network of research centres and university hospitals.”
The Pointe-Claire facility, which employs over 400 people, will house the company’s production and R&D operations along with its catheter treatment teaching activities, carried on in close cooperation with the Montreal Heart Institute. About 50 jobs will be created over the next three years.
The Cryoballoon: A Québec Invention
Did you know that Medtronic CryoCath’s “cryoballoon,” a catheter used in cryotherapy, was created and is produced in Québec? This new procedure enables millions of people with atrial fibrillation, the most common heart disorder, to live without drug therapy. Read more